Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-26 7:57 pm Sale | 2024-03-22 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 2,813,837 5.400% | -834,459 (-22.87%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2024-01-30 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 3,648,296 6.900% | 171,215 (+4.92%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2023-07-28 | 13D | Inozyme Pharma, Inc. INZY | Sofinnova Venture Partners X L.P. | 4,280,308 6.900% | 2,252,000 (+111.03%) | Filing History |
| 2024-02-20 7:09 pm Purchase | 2023-06-21 | 13D | Aerovate Therapeutics, Inc. AVTE | Sofinnova Venture Partners X L.P. | 3,807,315 13.800% | 23,683 (+0.63%) | Filing History |
| 2023-06-20 8:56 pm Sale | 2023-06-14 | 13D | Karuna Therapeutics, Inc. KRTX | Sofinnova Venture Partners X L.P. | 1,439,649 3.800% | -386,975 (-21.19%) | Filing History |
| 2023-03-01 1:38 pm Sale | 2023-02-24 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Venture Partners X L.P. | 0 0.000% | -6,109,360 (Position Closed) | Filing History |
| 2023-02-13 8:43 pm Purchase | 2023-02-06 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 3,477,081 8.300% | 285,714 (+8.95%) | Filing History |
| 2023-02-03 7:24 pm Purchase | 2022-11-14 | 13D | Aerovate Therapeutics, Inc. AVTE | Sofinnova Venture Partners X L.P. | 3,783,632 15.400% | 23,558 (+0.63%) | Filing History |
| 2023-02-03 7:11 pm Purchase | 2023-01-12 | 13D | Karuna Therapeutics, Inc. KRTX | Sofinnova Venture Partners X L.P. | 1,826,624 5.300% | 97,272 (+5.62%) | Filing History |
| 2023-02-03 7:07 pm Purchase | 2022-03-28 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 3,191,367 11.500% | 276,591 (+9.49%) | Filing History |
| 2022-08-19 5:38 pm Purchase | 2022-08-11 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Venture Partners X L.P. | 6,109,360 14.300% | 535,411 (+9.61%) | Filing History |
| 2022-02-14 6:45 pm Purchase | 2021-11-04 | 13D | Y-mAbs Therapeutics, Inc. YMAB | Sofinnova Venture Partners X L.P. | 2,271,611 5.200% | 160,222 (+7.59%) | Filing History |
| 2022-01-21 3:19 pm Purchase | 2022-01-11 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Venture Partners X L.P. | 5,573,949 15.300% | 5,573,949 (New Position) | Filing History |
| 2021-07-13 1:49 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | Sofinnova Venture Partners X L.P. | 3,760,074 16.300% | 3,760,074 (New Position) | Filing History |
| 2021-05-24 1:46 pm Purchase | 2021-05-18 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 2,914,776 14.500% | 2,914,776 (New Position) | Filing History |
| 2021-03-04 06:20 am Purchase | 2020-07-28 | 13D | Inozyme Pharma, Inc. INZY | Sofinnova Venture Partners X L.P. | 2,028,308 8.700% | 2,028,308 (New Position) | Filing History |
| 2021-02-16 2:14 pm Purchase | 2021-02-04 | 13D | Bolt Biotherapeutics, Inc. BOLT | Sofinnova Venture Partners X L.P. | 2,754,437 8.000% | 2,754,437 (New Position) | Filing History |